Sanofi-India Stock/Share Prices, Buy and Sell Sanofi-India BSE Stocks

Sanofi India Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

15 Feb 2019 | 03:59 PM

6,217.25

-42.75 (-0.68%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

26.78%

Return (1Y)

Beaten S&P BSE Healthcare by 33.17%
Less Volatile

1.11%

Standard Deviation (1Y)

Lower than S&P BSE Healthcare by 0.01%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

6,840

4,706

News & Announcements

Sanofi India schedules board meeting
5 days ago

Sanofi India schedules board meeting

11 - Feb - 2019 12:00 AM | 5 days ago

Sanofi India will hold a meeting of the Board of Directors of the Company on 26 February 2019.
Powered by Capital Market - Live News
Directorate of Health Services signs 3 year partnership with Sanofi India
15 days ago

Directorate of Health Services signs 3 year partnership with Sanofi India

01 - Feb - 2019 12:00 AM | 15 days ago

The Directorate of Health Services has announced a 3-year partnership with Sanofi India to build awareness of diabetes and its management, for a better quality of life.
Through this Corporate Social Responsibility (CSR) collaboration,Sanofi India's team of medical experts and diabetologists will educate and upskill the State department's healthcare personnel serving the Rashtriya Bal Swasthya Karyakram (RBSK) cell; and the Medical Officers of the Health and Wellness centers. Alongside, Directorate of Health services will also partner Sanofi India to run its international programme KiDS (Kids and Diabetes in School), to raise awareness of diabetes amongst school children.
Powered by Capital Market - Live News
Sanofi India launches new ad campaign for topical analgesic - Combiflam® ICYHOTTM
26 days ago

Sanofi India launches new ad campaign for topical analgesic - Combiflam® ICYHOTTM

21 - Jan - 2019 12:00 AM | 26 days ago

Sanofi India has launched the new ad campaign for their topicalanalgesic - Combiflam® ICYHOTTM to provide effective relief to people suffering from strong pains.
Powered by Capital Market - Live News
Sanofi India standalone net profit rises 2.49% in the September 2018 quarter
108 days ago

Sanofi India standalone net profit rises 2.49% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 108 days ago

Net profit of Sanofi India rose 2.49% to Rs 119.20 crore in the quarter ended September 2018 as against Rs 116.30 crore during the previous quarter ended September 2017. Sales rose 11.81% to Rs 700.60 crore in the quarter ended September 2018 as against Rs 626.60 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 700.60 626.60 12
OPM % 26.73 29.32 -
PBDT 213.50 204.50 4
PBT 187.50 178.80 5
NP 119.20 116.30 2
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Sanofi India Ltd has decreased by -12.15% since past 1 Year
MF shareholding in Sanofi India Ltd has increased by 18.43% since past 1 Year
GovT shareholding in Sanofi India Ltd has decreased by -100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	700.60	626.60	12
OPM %	26.73	29.32	-
PBDT	213.50	204.50	4
PBT	187.50	178.80	5
NP	119.20	116.30	2

General Notifications

My Notifications

Research Notifications

Sanofi India Ltd NSE / BSE Pharmaceuticals, Large Cap

6,217.25 -42.75 (-0.68%)

News & Announcements

Price vs Volume

Stock Trivia

Sanofi India Ltd NSE / BSE
Pharmaceuticals, Large Cap

6,217.25

-42.75 (-0.68%)